COMPARATIVE ANALYSIS OF DONOR BLOOD PRESERVATION AND THE PREPARATION OF BLOOD COMPONENTS AND BLOOD-DERIVED PRODUCTS IN UZBEKISTAN IN 2024-2025

In recent years, Uzbekistan has placed particular emphasis on improving blood services, promoting blood donation, and increasing domestic production of blood-derived products. The aim of the study was to compare the volume of conservation of donated blood, blood components and the manufacture of certain biological blood-based drugs in Uzbekistan in 2024 and 2025, for which the consolidated statistical data of the Republican Blood Service for 2024 and 2025 were analyzed. In 2025, conservation blood volume increased by 8.62% compared to 2024, while decommissioned blood decreased by 12.0% due to expiration date. Erythrocytic mass increased by 10.54%, plasma by 6.46%, platelet mass by 31.3%, cryoprecipitate by 4.5%, antistaphylococcal plasma by 21-17.2%, and anti-staphylococcal immunoglobulin by 65-7. 5%. 520 doses of human normal immunoglobulin were prepared; it was not produced in 2024. However, 10% and 20% albumin decreased by 29.5% and 13.4%, respectively, and antirezus immunoglobulin by 19.7%.